SCHEMBL20230480

SCHEMBL20230480

c1ccc(-c2nc3c(-n4c5ccccc5c5cc(-n6c7ccccc7c7ccccc76)ccc54)nnc(-n4c5ccccc5c5cc(-n6c7ccccc7c7ccccc76)ccc54)c3nc2-c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
RAC2 P15153 1/20 0.37
RAC3 P60763 1/20 0.37
CDC42 P60953 1/20 0.37
RAC1 P63000 1/20 0.37
NPY5R Q15761 1/20 0.36
ALDH1A1 P00352 3/20 0.36
KHK P50053 1/20 0.36
NPSR1 Q6W5P4 5/20 0.35
KMT2A Q03164 5/20 0.35
HTT P42858 3/20 0.35
MAPT P10636 2/20 0.35
MAPK1 P28482 1/20 0.35
MEN1 O00255 4/20 0.34
DHFR P00374 1/20 0.33
PIK3CG P48736 1/20 0.33
PTGER1 P34995 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20230477 0.89 ALDH1A1 (0.43) KDM4EATML3MBTL1ALDH1A1NPSR1
SCHEMBL20230482 0.87 PDE10A (0.37) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL20230481 0.85 KDM4E (0.36) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL21778276 0.85 KDM4E (0.42) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL20230502 0.84 KDM4E (0.42) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL24596554 0.82 KDM4E (0.47) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL18415423 0.81 HSD17B10 (0.42) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL20230504 0.80 ADORA1 (0.40) RAC2RAC3CDC42RAC1ALDH1A1
SCHEMBL24596515 0.80 MEN1 (0.39) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL19653786 0.79 L3MBTL1 (0.41) KDM4EATML3MBTL1RAC2RAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10388887-B2 Delayed fluorescence compound for organic EL device and using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2019-08-20 US disclosed
US-20180159049-A1 DELAYED FLUORESCENCE COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2018-06-07 US disclosed
US-20180159049-A1 DELAYED FLUORESCENCE COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2018-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10388887-B2 Delayed fluorescence compound for organic EL device and using the same SLCO4C1, SLCO1A2, SLCO1B1 KDM4E 1233/4885ATM 3879/4885L3MBTL1 232/4885
US-20180159049-A1 DELAYED FLUORESCENCE COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME SLCO4C1, SLCO1A2, SLCO1B1 KDM4E 1233/4885ATM 3879/4885L3MBTL1 232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.